stockportfolio.pro
Stocks / HSTM vs ZVRA
HSTM vs ZVRA
HealthStream, Inc. and Zevra Therapeutics, Inc. side by side — fundamentals from SEC filings, refreshed nightly. Sector: Healthcare.
| HealthStream, Inc. (HSTM) | Zevra Therapeutics, Inc. (ZVRA) | |
|---|---|---|
| Market cap | $0.8B | $0.8B |
| Revenue (latest FY) | $304.06M | $106.47M |
| Net income (latest FY) | $18.34M | $83.23M |
| Revenue growth (5y CAGR) | 4.4% | 51.6% |
| Net margin | 6.0% | 78.2% |
| Return on equity | 5.2% | 53.8% |
| P/E ratio | 39.2 | 6.4 |
| Dividend yield | 0.5% | — |
| Profitable years (of last 10) | 10 | 1 |
| Positive free cash flow | Yes | No |
Compare them properly — statement by statement
Open either company interactively: 19 years of income statement, balance sheet and cash flow, ratios, health checks, and Ask — the SEC-grounded research assistant.
Open HSTM — free Open ZVRA — freeFrequently asked questions
Which is bigger, HSTM or ZVRA?
HealthStream, Inc. is larger by market capitalization — $0.8B versus $0.8B.
Which grows faster, HSTM or ZVRA?
Over the last five fiscal years, Zevra Therapeutics, Inc. grew revenue faster — 51.6%/yr versus 4.4%/yr, computed from SEC-filed statements.
Where does this data come from?
All figures are computed from official SEC filings (10-K), refreshed nightly. This is a data comparison, not investment advice.